Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA Dataset

21 Jan 2019

Abstract excerpt

Data from the Cancer Genome Atlas (TCGA) are now easily accessible through web-based platforms with tools to assess the prognostic value of molecular alterations. Pancreatic tumors have heterogeneous biology and aggressiveness ranging from the deadly adenocarcinoma (PDAC) to the better prognosis, neuroendocrine tumors. We assessed the availability of the pancreatic cancer TCGA data (TCGA_PAAD) from several...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30669703
DOI: 10.3390/cancers11010126

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Biomarkers in Pancreatic Cancer: Avoiding Errata When Using the TCGA DatasetPMID 30669703Read ↗

Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.Semantic proximity Read ↗

Curation of the Pancreatic Ductal Adenocarcinoma Subset of the Cancer Genome Atlas Is Essential for Accurate Conclusions about Survival-Related Molecular MechanismsSemantic proximity Read ↗

A transcriptomics-based meta-analysis combined with machine learning approach identifies a secretory biomarker panel for diagnosis of pancreatic adenocarcinomaSemantic proximity Read ↗

Pancreatic biomarkers: could they be the answer?Semantic proximity Read ↗

Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factorsSemantic proximity Read ↗

WITHDRAWN: Identifying diagnostic markers and constructing a prognostic model for pancreatic cancer based on microarray and bioinformatic analysisSemantic proximity Read ↗

Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.Semantic proximity Read ↗

Identification of Blood-based Non-invasive Biomarkers and Therapeutic Agents against Pancreatic Ductal Adenocarcinoma (PDAC): A Network-based StudySemantic proximity Read ↗

A prognostic model for anoikis-related genes in pancreatic cancer.Semantic proximity Read ↗

Open-source curation of a pancreatic ductal adenocarcinoma gene expression analysis platform (pdacR) supports a two-subtype modelSemantic proximity Read ↗

Pancreatic cancer survival analysis defines a signature that predicts outcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.